Financial Summary (All financials)
| In millions, except per share items | Jan-02-22 | Jan-03-21 | Dec-29-19 | Dec-30-18 | Dec-31-17 | Jan-01-17 | Jan-03-16 | Dec-28-14 |
| Revenues | 93,775.0 | 82,584.0 | 82,059.0 | 81,581.0 | 76,450.0 | 71,890.0 | 70,074.0 | 74,331.0 |
| Revenue growth | 13.6% | 0.6% | 0.6% | 6.7% | 6.3% | 2.6% | -5.7% | 4.2% |
| Cost of goods sold | 29,855.0 | 28,427.0 | 27,556.0 | 27,091.0 | 25,439.0 | 21,789.0 | 21,536.0 | 22,746.0 |
| Gross profit | 63,920.0 | 54,157.0 | 54,503.0 | 54,490.0 | 51,011.0 | 50,101.0 | 48,538.0 | 51,585.0 |
| Gross margin | 68.2% | 65.6% | 66.4% | 66.8% | 66.7% | 69.7% | 69.3% | 69.4% |
| Selling, general and administrative | 24,659.0 | 22,084.0 | 22,178.0 | 22,540.0 | 21,520.0 | 20,067.0 | 21,203.0 | 21,954.0 |
| Research and development | 14,714.0 | 12,159.0 | 11,355.0 | 10,775.0 | 10,594.0 | 9,143.0 | 9,046.0 | 8,494.0 |
| EBITA | 29,247.0 | 24,614.0 | 25,470.0 | 25,575.0 | 21,897.0 | 22,091.0 | 19,489.0 | 22,537.0 |
| EBITA margin | 31.2% | 29.8% | 31.0% | 31.3% | 28.6% | 30.7% | 27.8% | 30.3% |
| Amortization of intangibles | 4,700.0 | 4,700.0 | 4,500.0 | 4,400.0 | 3,000.0 | 1,200.0 | 1,200.0 | 1,400.0 |
| EBIT | 24,547.0 | 19,914.0 | 20,970.0 | 21,175.0 | 18,897.0 | 20,891.0 | 18,289.0 | 21,137.0 |
| EBIT margin | 26.2% | 24.1% | 25.6% | 26.0% | 24.7% | 29.1% | 26.1% | 28.4% |
| Pre-tax income | 22,776.0 | 16,497.0 | 17,328.0 | 17,999.0 | 17,673.0 | 19,803.0 | 19,196.0 | 20,563.0 |
| Income taxes | 1,898.0 | 1,783.0 | 2,209.0 | 2,702.0 | 16,373.0 | 3,263.0 | 3,787.0 | 4,240.0 |
| Tax rate | 8.3% | 10.8% | 12.7% | 15.0% | 92.6% | 16.5% | 19.7% | 20.6% |
| Net income | 20,878.0 | 14,714.0 | 15,119.0 | 15,297.0 | 1,300.0 | 16,540.0 | 15,409.0 | 16,323.0 |
| Net margin | 22.3% | 17.8% | 18.4% | 18.8% | 1.7% | 23.0% | 22.0% | 22.0% |
| |
| Diluted EPS | $7.81 | $5.51 | $5.63 | $5.61 | $0.47 | $5.93 | $5.48 | $5.70 |
| Shares outstanding (diluted) | 2,674.0 | 2,670.7 | 2,684.3 | 2,728.7 | 2,745.3 | 2,788.9 | 2,812.9 | 2,863.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|